US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.750
  • -0.064-7.83%
Trading Nov 21 11:31 ET
128.09MMarket Cap-3572P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
41.47%-34.68M
-160.33%-39.81M
53.99%-35.24M
48.71%-117.35M
10.20%-47.5M
0.55%-59.26M
232.24%65.98M
-15.26%-76.58M
-3,521.29%-228.82M
-1.98%-52.89M
Net income from continuing operations
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
Operating gains losses
-12,089.33%-123.36M
---130K
---123K
--71K
---410K
---1.01M
----
----
----
----
Depreciation and amortization
-16.63%1.4M
-7.01%1.42M
11.36%1.56M
-5.82%6.24M
0.31%1.63M
-3.61%1.68M
-9.38%1.53M
-10.83%1.4M
11.47%6.63M
4.83%1.63M
Other non cash items
42.38%2.91M
-35.21%2.87M
-51.26%2.86M
118.78%15.17M
14.30%2.83M
-19.30%2.04M
158.79%4.43M
2,627.44%5.86M
70.39%6.93M
-2.37%2.48M
Change In working capital
57.90%-9.59M
-1,036.41%-16.64M
52.67%-9.15M
-220.68%-58.98M
-442.13%-15.39M
-120.19%-22.79M
-132.84%-1.46M
-13.76%-19.34M
-144.28%-18.39M
144.87%4.5M
-Change in receivables
300.05%18.6M
-47.94%-11.18M
--1.26M
---8.67M
--8.18M
---9.3M
---7.56M
--0
--0
--0
-Change in inventory
20.78%-10.45M
-106.44%-11.02M
---12.33M
---29.65M
---11.12M
---13.19M
---5.34M
--0
--0
--0
-Change in prepaid assets
-110.70%-2.27M
-451.40%-1.88M
44.74%4.41M
-131.16%-29.12M
-10,642.67%-31.63M
60.97%-1.08M
108.49%535K
179.25%3.04M
-2.12%-12.6M
104.09%300K
-Change in payables and accrued expense
-100.98%-9.06M
-3.83%9.68M
88.40%-2.65M
-23.09%4.26M
267.81%21.54M
-63.31%-4.51M
-20.12%10.07M
-124.83%-22.84M
-89.43%5.54M
26.04%5.86M
-Change in other current liabilities
-99.05%-2.11M
-300.59%-2.04M
-225.37%-218K
47.73%-2.2M
17.72%-562K
23.88%-1.06M
18.14%-510K
95.55%-67K
-18.39%-4.2M
49.96%-683K
-Change in other working capital
-168.10%-4.32M
-113.91%-187K
-27.39%379K
189.86%6.41M
-84.51%-1.8M
284.03%6.34M
210.53%1.34M
134.96%522K
-63.60%-7.13M
86.50%-975K
Cash from discontinued investing activities
Operating cash flow
41.47%-34.68M
-160.33%-39.81M
53.99%-35.24M
48.71%-117.35M
10.20%-47.5M
0.55%-59.26M
232.24%65.98M
-15.26%-76.58M
-3,521.29%-228.82M
-1.98%-52.89M
Investing cash flow
Cash flow from continuing investing activities
7,954.37%141.14M
-87.62%1.3M
-102.26%-62K
-87.16%10.58M
-114.80%-877K
-104.48%-1.8M
-55.05%10.52M
-78.89%2.74M
28.62%82.43M
-55.06%5.93M
Net PPE purchase and sale
92.82%-129K
91.97%-99K
98.48%-62K
18.80%-7.98M
74.66%-877K
-44.11%-1.8M
43.00%-1.23M
-37.90%-4.07M
-2.67%-9.82M
-119.33%-3.46M
Net investment purchase and sale
--0
--0
--0
-79.88%18.56M
--0
--0
-54.03%11.75M
-57.25%6.81M
25.25%92.25M
-33.02%9.39M
Net other investing changes
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
7,954.37%141.14M
-87.62%1.3M
-102.26%-62K
-87.16%10.58M
-114.80%-877K
-104.48%-1.8M
-55.05%10.52M
-78.89%2.74M
28.62%82.43M
-55.06%5.93M
Financing cash flow
Cash flow from continuing financing activities
-7,783.37%-110.87M
0
231.72%18.76M
-44.67%71.71M
39.85%6.43M
-98.53%1.44M
44,651.54%58.18M
-78.93%5.66M
10,901.87%129.6M
689.36%4.6M
Net issuance payments of debt
---127.91M
----
----
96.58%50.52M
--0
--0
----
----
2,810.86%25.7M
--0
Net common stock issuance
--3.38M
--0
334.28%18.41M
-82.05%18.16M
450.43%6.43M
--0
--7.49M
--4.24M
--101.17M
--1.17M
Proceeds from stock option exercised by employees
-90.71%134K
--0
-75.09%353K
10.71%3.03M
--0
10.49%1.44M
29.23%168K
23.32%1.42M
28.65%2.74M
-10.71%150K
Cash from discontinued financing activities
Financing cash flow
-7,783.37%-110.87M
--0
231.72%18.76M
-44.67%71.71M
39.85%6.43M
-98.53%1.44M
44,651.54%58.18M
-78.93%5.66M
10,901.87%129.6M
689.36%4.6M
Net cash flow
Beginning cash position
-65.88%81.11M
16.10%119.61M
-20.48%136.15M
-8.93%171.22M
-16.61%178.1M
76.07%237.71M
-36.16%103.03M
-8.93%171.22M
62.00%188M
-6.10%213.58M
Current changes in cash
92.61%-4.41M
-128.59%-38.51M
75.75%-16.54M
-108.91%-35.07M
1.00%-41.95M
-175.86%-59.61M
610.76%134.68M
-156.11%-68.19M
-123.33%-16.79M
-7.38%-42.37M
Effect of exchange rate changes
--0
----
----
300.00%2K
--0
150.00%1K
----
----
0.00%-1K
200.00%1K
End cash Position
-56.94%76.7M
-65.88%81.11M
16.10%119.61M
-20.48%136.15M
-20.48%136.15M
-16.61%178.1M
76.07%237.71M
-36.16%103.03M
-8.93%171.22M
-8.93%171.22M
Free cash flow
42.98%-34.81M
-161.64%-39.91M
56.23%-35.3M
47.48%-125.33M
14.16%-48.38M
-0.37%-61.05M
224.38%64.75M
-16.22%-80.65M
-8,191.77%-238.64M
-5.45%-56.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 41.47%-34.68M-160.33%-39.81M53.99%-35.24M48.71%-117.35M10.20%-47.5M0.55%-59.26M232.24%65.98M-15.26%-76.58M-3,521.29%-228.82M-1.98%-52.89M
Net income from continuing operations 285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M
Operating gains losses -12,089.33%-123.36M---130K---123K--71K---410K---1.01M----------------
Depreciation and amortization -16.63%1.4M-7.01%1.42M11.36%1.56M-5.82%6.24M0.31%1.63M-3.61%1.68M-9.38%1.53M-10.83%1.4M11.47%6.63M4.83%1.63M
Other non cash items 42.38%2.91M-35.21%2.87M-51.26%2.86M118.78%15.17M14.30%2.83M-19.30%2.04M158.79%4.43M2,627.44%5.86M70.39%6.93M-2.37%2.48M
Change In working capital 57.90%-9.59M-1,036.41%-16.64M52.67%-9.15M-220.68%-58.98M-442.13%-15.39M-120.19%-22.79M-132.84%-1.46M-13.76%-19.34M-144.28%-18.39M144.87%4.5M
-Change in receivables 300.05%18.6M-47.94%-11.18M--1.26M---8.67M--8.18M---9.3M---7.56M--0--0--0
-Change in inventory 20.78%-10.45M-106.44%-11.02M---12.33M---29.65M---11.12M---13.19M---5.34M--0--0--0
-Change in prepaid assets -110.70%-2.27M-451.40%-1.88M44.74%4.41M-131.16%-29.12M-10,642.67%-31.63M60.97%-1.08M108.49%535K179.25%3.04M-2.12%-12.6M104.09%300K
-Change in payables and accrued expense -100.98%-9.06M-3.83%9.68M88.40%-2.65M-23.09%4.26M267.81%21.54M-63.31%-4.51M-20.12%10.07M-124.83%-22.84M-89.43%5.54M26.04%5.86M
-Change in other current liabilities -99.05%-2.11M-300.59%-2.04M-225.37%-218K47.73%-2.2M17.72%-562K23.88%-1.06M18.14%-510K95.55%-67K-18.39%-4.2M49.96%-683K
-Change in other working capital -168.10%-4.32M-113.91%-187K-27.39%379K189.86%6.41M-84.51%-1.8M284.03%6.34M210.53%1.34M134.96%522K-63.60%-7.13M86.50%-975K
Cash from discontinued investing activities
Operating cash flow 41.47%-34.68M-160.33%-39.81M53.99%-35.24M48.71%-117.35M10.20%-47.5M0.55%-59.26M232.24%65.98M-15.26%-76.58M-3,521.29%-228.82M-1.98%-52.89M
Investing cash flow
Cash flow from continuing investing activities 7,954.37%141.14M-87.62%1.3M-102.26%-62K-87.16%10.58M-114.80%-877K-104.48%-1.8M-55.05%10.52M-78.89%2.74M28.62%82.43M-55.06%5.93M
Net PPE purchase and sale 92.82%-129K91.97%-99K98.48%-62K18.80%-7.98M74.66%-877K-44.11%-1.8M43.00%-1.23M-37.90%-4.07M-2.67%-9.82M-119.33%-3.46M
Net investment purchase and sale --0--0--0-79.88%18.56M--0--0-54.03%11.75M-57.25%6.81M25.25%92.25M-33.02%9.39M
Net other investing changes --0------------------------------------
Cash from discontinued investing activities
Investing cash flow 7,954.37%141.14M-87.62%1.3M-102.26%-62K-87.16%10.58M-114.80%-877K-104.48%-1.8M-55.05%10.52M-78.89%2.74M28.62%82.43M-55.06%5.93M
Financing cash flow
Cash flow from continuing financing activities -7,783.37%-110.87M0231.72%18.76M-44.67%71.71M39.85%6.43M-98.53%1.44M44,651.54%58.18M-78.93%5.66M10,901.87%129.6M689.36%4.6M
Net issuance payments of debt ---127.91M--------96.58%50.52M--0--0--------2,810.86%25.7M--0
Net common stock issuance --3.38M--0334.28%18.41M-82.05%18.16M450.43%6.43M--0--7.49M--4.24M--101.17M--1.17M
Proceeds from stock option exercised by employees -90.71%134K--0-75.09%353K10.71%3.03M--010.49%1.44M29.23%168K23.32%1.42M28.65%2.74M-10.71%150K
Cash from discontinued financing activities
Financing cash flow -7,783.37%-110.87M--0231.72%18.76M-44.67%71.71M39.85%6.43M-98.53%1.44M44,651.54%58.18M-78.93%5.66M10,901.87%129.6M689.36%4.6M
Net cash flow
Beginning cash position -65.88%81.11M16.10%119.61M-20.48%136.15M-8.93%171.22M-16.61%178.1M76.07%237.71M-36.16%103.03M-8.93%171.22M62.00%188M-6.10%213.58M
Current changes in cash 92.61%-4.41M-128.59%-38.51M75.75%-16.54M-108.91%-35.07M1.00%-41.95M-175.86%-59.61M610.76%134.68M-156.11%-68.19M-123.33%-16.79M-7.38%-42.37M
Effect of exchange rate changes --0--------300.00%2K--0150.00%1K--------0.00%-1K200.00%1K
End cash Position -56.94%76.7M-65.88%81.11M16.10%119.61M-20.48%136.15M-20.48%136.15M-16.61%178.1M76.07%237.71M-36.16%103.03M-8.93%171.22M-8.93%171.22M
Free cash flow 42.98%-34.81M-161.64%-39.91M56.23%-35.3M47.48%-125.33M14.16%-48.38M-0.37%-61.05M224.38%64.75M-16.22%-80.65M-8,191.77%-238.64M-5.45%-56.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.05%